Tag: #Carbapenemase

Introduction Antimicrobial resistance has emerged as one of the most critical global health challenges, particularly in the management of urinary tract infections (UTIs). Recent molecular evidence from Tunisia highlights an alarming rise in extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae, especially Escherichia coli and Klebsiella pneumoniae. These pathogens significantly limit treatment options and increase healthcare burdens.…